As mentioned earlier, stromal GREM1 expression has been demonstrated not only in BCCs but also in many invasive carcinomas, such as carcinomas of the esophagus, pancreas, colon, lung, breast, and mesotheliomas [7, 21]. Here, GREM1 is linked to invasive carcinoma.